Mount Sinai Celebrates Groundbreaking for the Tisch Cancer Hospital

From left: Brendan G. Carr, MD, MA, MS; Merryl H. Tisch, EdD; and James S. Tisch, Chairman Emeritus of the Mount Sinai Health System Boards of Trustees 

In his remarks, Mount Sinai CEO Brendan G. Carr, MD, MA, MS, Professor and Kenneth L. Davis, MD Distinguished Chair, reflected on the intentionality behind the Tisches’ extraordinary gift and the lasting difference it will make for people facing cancer. “This will be an incredible, long-standing testament to your family’s gift to New York and beyond, and especially to the patients who have cancer,” he said. “All of our families have been touched by cancer, I’m certain. And it is a massive thing to get comfort during people’s most trying times. On behalf of Mount Sinai, thank you.”

Opening in 2030 on Mount Sinai’s Upper East Side campus, the Mount Sinai Tisch Cancer Hospital will build on the Mount Sinai Tisch Cancer Center’s distinction as a National Cancer Institute-designated Comprehensive Cancer Center—the highest designation awarded to cancer centers in the United States, placing Mount Sinai among the top one percent nationally. The new hospital is envisioned as an ultra-modern, deeply compassionate environment where breakthrough science and whole-person care are closely connected, bringing patients, families, clinicians, and researchers together in one singular place of hope and healing.

Mr. Tisch spoke warmly about his family’s long partnership with Mount Sinai and their pride in supporting a project that will shape its future. “Mount Sinai is in my heart,” he said, recalling nearly four decades of involvement with the institution. Of the new hospital, he added, “We decided that this was a great family legacy to be behind... we are excited about this hospital that’s being built... the research that’s being done... and the people who are being trained here at Mount Sinai. I think that Mount Sinai’s future looks fabulous going forward.”

Dr. Carr also underscored the extraordinary scale of Mount Sinai’s cancer program and the patient-centered mission at the heart of this investment. He noted that Mount Sinai recorded 300,000 ambulatory oncology visits last year across 13 locations, supported by 280 cancer specialists, and cared for nearly 10,000 people diagnosed with cancer or being evaluated for it. “Just a reminder that everything that we do is rooted in patient care,” he said. 

At its heart, the groundbreaking was a celebration of generosity, vision, and shared purpose. It marks the beginning of a project that will transform the experience of cancer care at Mount Sinai—creating a warm, welcoming, and state-of-the-art hospital where patients are surrounded by expertise, innovation, and the comfort of those who care for them. For the Tisch family, Mount Sinai leadership, and all those gathered, the moment offered a powerful glimpse of what the new hospital will make possible for generations to come.